Medicine recalls
|
| |
| Further Recall of Mecotuss Cap and Lyhexine Cap |
| |
The Department of Health (DH) today (March 26) endorsed a licensed manufacturer, Meyer Pharmaceuticals Ltd (Meyer), to recall all batches of Mecotuss Cap (HK-35597) and Lyhexine Cap (HK-37207) from the market as a precautionary measure due to potential stability issue.
Following the batch recall of the above two products on January 26, 2024, further investigations conducted by Meyer revealed that the two products when storing under high temperature and humidity may have stability issue but would not be harmful to users. As a precautionary measure, Meyer is voluntarily recalling all the batches of these two products from the market.
The above two products are over-the-counter medicines used for the relief of cold and cough symptoms. According to Meyer, the products have been supplied to local private doctors, pharmacies and medicine companies.
Meyer has set up a hotline (2601 2670) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the above products. The DH will closely monitor the recall.
Members of the public taking the above products should consult their healthcare professionals if in doubt for appropriate arrangements.
Ends/Tuesday, Mar 26, 2024
Issued at HKT 17:00 |
| |
